Cargando…

Validation and modification of staging Systems for Poorly Differentiated Pancreatic Neuroendocrine Carcinoma

BACKGROUND: The American Joint Committee on Cancer (AJCC) and the European Neuroendocrine Tumor Society (ENETS) staging classifications are two broadly used systems for pancreatic neuroendocrine tumors. This study aims to identify the most accurate and useful tumor–node–metastasis (TNM) staging syst...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Haihong, Lin, Zhenyu, Li, Guiling, Zhang, Dejun, Yu, Dandan, Lin, Qili, Wang, Jing, Zhao, Ye, Pi, Guoliang, Zhang, Tao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7059325/ https://www.ncbi.nlm.nih.gov/pubmed/32138704 http://dx.doi.org/10.1186/s12885-020-6634-9

Ejemplares similares

Meta-analysis and indirect treatment comparison of modified FOLFIRINOX and gemcitabine plus nab-paclitaxel as first-line chemotherapy in advanced pancreatic cancer
por: Chen, Jiayuan, et al.
Publicado: (2021)

Cause of death among patients with colorectal cancer: a population-based study in the United States
por: Chen, Jiayuan, et al.
Publicado: (2020)

Establishment and validation of an AJCC stage- and histologic grade-based nomogram for pancreatic neuroendocrine tumors after surgical resection
por: Zhang, Chuanzhao, et al.
Publicado: (2019)

Endocan expression is correlated with poor progression-free survival in patients with pancreatic neuroendocrine tumors
por: Lin, Liang-Yu, et al.
Publicado: (2017)

Low accuracy of chromogranin A for diagnosing early-stage pancreatic neuroendocrine tumors
por: Tseng, Chao-Ming, et al.
Publicado: (2018)

Decreased expression of LKB1 predicts poor prognosis in pancreatic neuroendocrine tumor patients undergoing curative resection
por: Li, Dezhi, et al.
Publicado: (2018)

Clinicopathological features and prognostic validity of the European Neuroendocrine Tumor Society (ENETS) and American Joint Committee on Cancer (AJCC) 8th staging systems in colonic neuroendocrine neoplasms
por: Zhang, Yu, et al.
Publicado: (2019)

A real-life treatment cohort of pancreatic neuroendocrine tumors: High-grade increase in metastases confers poor survival
por: Zhang, Wu-Hu, et al.
Publicado: (2022)

Neuroendocrine Differentiation Is a Prognostic Factor for Stage II Poorly Differentiated Colorectal Cancer
por: Liu, Yue, et al.
Publicado: (2014)

Consideration of Age Is Necessary for Increasing the Accuracy of the AJCC TNM Staging System of Pancreatic Neuroendocrine Tumors
por: Wang, Zhengshi, et al.
Publicado: (2019)

TNM Staging of Pancreatic Neuroendocrine Tumors: An Observational Analysis and Comparison by Both AJCC and ENETS Systems From 1 Single Institution
por: Yang, Min, et al.
Publicado: (2015)

Neuroendocrine differentiation is predictive of poor survival in patients with stage II colorectal cancer
por: Liu, Yue, et al.
Publicado: (2017)

Pancreatic neuroendocrine tumors G3 and pancreatic neuroendocrine carcinomas: Differences in basic biology and treatment
por: Zhang, Ming-Yi, et al.
Publicado: (2020)

Surgical resection of primary tumor improves survival of pancreatic neuroendocrine tumor with liver metastases
por: Tao, Lianyuan, et al.
Publicado: (2017)

Nonfunctional pancreatic neuroendocrine tumours misdiagnosed as autoimmune pancreatitis: A case report and review of literature
por: Lin, Zi-Qi, et al.
Publicado: (2022)

Surgical Outcomes, Long-Term Survivals and Staging Systems of World Health Organization G3 Pancreatic Neuroendocrine Tumors
por: Yang, Min, et al.
Publicado: (2022)

Metronomic temozolomide as second line treatment for metastatic poorly differentiated pancreatic neuroendocrine carcinoma
por: De Divitiis, C., et al.
Publicado: (2016)

Poor outcome after systemic therapy in secondary high-grade pancreatic neuroendocrine tumors
por: Mollazadegan, Kazhan, et al.
Publicado: (2022)

Validation of the eighth edition of the AJCC staging system for patients with pancreatic adenocarcinoma initially receiving chemoradiotherapy and proposal of modifications
por: Zhu, Xiaofei, et al.
Publicado: (2020)

Anticancer Effects of Baicalein in Pancreatic Neuroendocrine Tumors In Vitro and In Vivo
por: Tian, Ye, et al.
Publicado: (2017)

Screening and Validation of Independent Predictors of Poor Survival in Pancreatic Cancer
por: Liu, Shui, et al.
Publicado: (2021)

High expression of EGFR predicts poor survival in patients with resected T3 stage gastric adenocarcinoma and promotes cancer cell survival
por: Wang, Daiyong, et al.
Publicado: (2017)

Functional and non-functional pancreatic neuroendocrine tumours: ENETS or AJCC TNM staging system?
por: Yang, Min, et al.
Publicado: (2017)

A comprehensive validation of the novel 8th edition of American Joint Committee on Cancer staging manual for the long-term survivals of patients with non-functional pancreatic neuroendocrine neoplasms
por: Yang, Min, et al.
Publicado: (2020)

High-Dose Lanreotide in the Treatment of Poorly Differentiated Pancreatic Neuroendocrine Carcinoma: A Case Report
por: Van Fraeyenhove, Frank, et al.
Publicado: (2014)

Identification and Characterization of Poorly Differentiated Invasive Carcinomas in a Mouse Model of Pancreatic Neuroendocrine Tumorigenesis
por: Hunter, Karen E., et al.
Publicado: (2013)

CT and MR imaging features of mixed neuroendocrine–non-neuroendocrine neoplasm of the pancreas compared with pancreatic ductal adenocarcinoma and neuroendocrine tumor
por: Zhong, Yanqi, et al.
Publicado: (2023)

Pancreatic neuroendocrine neoplasms: Magnetic resonance imaging features according to grade and stage
por: De Robertis, Riccardo, et al.
Publicado: (2017)

Nonfunctional pancreatic neuroendocrine tumor masked as anemia: A case report
por: Xu, Baojin, et al.
Publicado: (2017)

Value of lymphadenectomy in patients with surgically resected pancreatic neuroendocrine tumors
por: Zhang, Zheng, et al.
Publicado: (2022)

Influence of Salvia miltiorrhizae on the Mesenteric Lymph Node of Rats with Severe Acute Pancreatitis or Obstructive Jaundice
por: Xiping, Zhang, et al.
Publicado: (2009)

Diabetes in Patients With Pancreatic Neuroendocrine Neoplasms
por: Zhuge, Xiaoling, et al.
Publicado: (2020)

Clonal Evolution Dynamics in Primary and Metastatic Lesions of Pancreatic Neuroendocrine Neoplasms
por: Tong, Zhou, et al.
Publicado: (2021)

Development and Validation of a Nomogram for Predicting Overall Survival in Pancreatic NeuroendocrineTumors()()
por: Miao, Dong-liu, et al.
Publicado: (2018)

High Expression of MicroRNA-196a Indicates Poor Prognosis in Resected Pancreatic Neuroendocrine Tumor
por: Lee, Yoon Suk, et al.
Publicado: (2015)

MYC regulates ductal-neuroendocrine lineage plasticity in pancreatic ductal adenocarcinoma associated with poor outcome and chemoresistance
por: Farrell, Amy S., et al.
Publicado: (2017)

Bone Loss in Patients with Pancreatic Neuroendocrine Tumors
por: Tong, He, et al.
Publicado: (2022)

Tumor CEMIP drives immune evasion of colorectal cancer via MHC-I internalization and degradation
por: Zhang, Biying, et al.
Publicado: (2023)

Orlistat Induces Ferroptosis in Pancreatic Neuroendocrine Tumors by Inactivating the MAPK Pathway
por: Ye, Mujie, et al.
Publicado: (2023)

Pancreatic paraganglioma mimicking pancreatic neuroendocrine tumor
por: Abbasi, Arezou, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ql98nq8tehe1p01sn6eicuvpbt